Atlas Trials

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

Clinical trial NCT03543189 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03543189
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate CancerProstate Disease
Start date
2018-10-03
Primary completion
2026-06-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.